Januvia
Product Images NDC 54868-5840

5 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 54868-5840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100 mg (100mg Package Label)

Bottle Label 100 mg (100mg Package Label)
Packaging label for JANUVIA 100 mg, distributed by Physicians Total Care, Inc., Tulsa, OK. The label includes the lot number, expiration date, and manufacturer information (Merck Sharp & Dohme, Italy). A barcode is also visible on the label.*
FDA Label Image

Image Of Structural Formula (228ec896 E0ca 40dc 932d Ee3b3c2ffff5 01)

Image Of Structural Formula (228ec896 E0ca 40dc 932d Ee3b3c2ffff5 01)
Chemical structure diagram of the active ingredient in JANUVIA, showing its molecular arrangement including fluorine-substituted aromatic rings and trifluoromethyl groups, presented as a hydrate phosphate salt.*
FDA Label Image

Image Of Figure 1 (228ec896 E0ca 40dc 932d Ee3b3c2ffff5 02)

Image Of Figure 1 (228ec896 E0ca 40dc 932d Ee3b3c2ffff5 02)
A line chart showing LS mean change from baseline over 24 weeks for different treatments: Placebo, Metformin 1000 mg b.i.d., Sitagliptin 100 mg q.d., Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d., and Sitagliptin 50 mg b.i.d. + Metformin 1000 mg b.i.d. Each treatment is represented by distinct symbols; the chart tracks changes in response by week for each group.*
FDA Label Image

Image Of Figure 2 (228ec896 E0ca 40dc 932d Ee3b3c2ffff5 03)

Image Of Figure 2 (228ec896 E0ca 40dc 932d Ee3b3c2ffff5 03)
Line graph comparing the least squares mean change from baseline over 52 weeks between Januvia 100 mg and Glipizide. The x-axis represents weeks from 0 to 52, and the y-axis shows change values from 0 to -1.5. Both treatments show a decrease initially, stabilizing between weeks 12 and 30, with slight increases near week 52.*
FDA Label Image

Bottle Label 50 mg (50mg Package Label)

Bottle Label 50 mg (50mg Package Label)
JANUVIA 50 mg (sitagliptin tablets) label from Physicians Total Care, Inc. The label includes product identification, strength, dosage form, package count of 90 tablets, and federal caution about dispensing without prescription. Additional text includes directions for use and storage instructions, along with lot number and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.